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and Biomedical Sciences Group, Biology and Soft Matter Division, Oak Ridge National Laboratory, Oak Ridge, TennesseeABSTRACT Acquiring detailed structural information about the various aggregation states of the huntingtin-exon1 protein
(Htt-exon1) is crucial not only for identifying the true nature of the neurotoxic species responsible for Huntington’s disease
(HD) but also for designing effective therapeutics. Using time-resolved small-angle neutron scattering (TR-SANS), we followed
the conformational changes that occurred during fibrillization of the pathologic form of Htt-exon1 (NtQ42P10) and compared the
results with those obtained for the wild-type (NtQ22P10). Our results show that the aggregation pathway of NtQ22P10 is very
different from that of NtQ42P10, as the initial steps require a monomer to 7-mer transition stage. In contrast, the earliest species
identified for NtQ42P10 are monomer and dimer. The divergent pathways ultimately result in NtQ22P10 fibrils that possess a pack-
ing arrangement consistent with the common amyloid sterical zipper model, whereas NtQ42P10 fibrils present a better fit to the
Perutz b-helix structural model. The structural details obtained by TR-SANS should help to delineate the key mechanisms that
underpin Htt-exon1 aggregation leading to HD.INTRODUCTIONHuntington’s disease (HD) is an incurable neurodegenera-
tive proteinopathy that is linked to the formation of
b-sheet-rich insoluble Htt-exon1 amyloid fibrils. The length
of the CAG repeat, which is located in the first exon of the
IT15 gene and encodes for glutamine (Q), is a key compo-
nent of the onset of HD (1). If the CAG repeat encodes
for more than 36 Q, the translated 350 kDa huntingtin pro-
tein will ultimately result in a proteolytic fragment and,
most notably, Htt-exon1, which contains the abnormal
expanded polyQ sequence (2,3). It is the presence of this
abnormal length of polyQ sequence that gives Htt-exon1
the capacity to aggregate and form amyloid fibrils that accu-
mulate into intraneuronal inclusions.
The critical release of Htt-exon1 to initiate HD pathology
is well documented. However, how this toxic fragment leads
to neuronal cell death is still unknown. Htt-exon1 has the
polyQ sequence flanked on its N-terminal side by a 17-res-
idue amphipathic a-helix and by a proline-rich region of 50
amino acids on its C-terminal side (4,5). The past 13 years
have seen conflicting evidence regarding the cytotoxic roleSubmitted February 4, 2014, and accepted for publication June 5, 2014.
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0006-3495/14/07/0411/11 $2.00of the Htt-exon1 fibrils, as their presence does not always
correlate with neuronal cell death (6–9). The fact that other
amyloid neurodegenerative diseases, including Alzheimer’s
and Parkinson’s, showed the same trend (10,11) led
researchers in the amyloid field to thoroughly investigate
the aggregation process with an emphasis on the oligomer-
ization phase to determine whether early-formed oligomers
could be the culprit.
Acquiring structural information about the assembly of
on-pathway oligomers and possibly the pathogenic agents
responsible for HD can be quite challenging because these
structures are highly unstable and difficult to isolate.
Various biophysical methods that are capable of examining
partially folded proteins in nonnative conformations and
supramolecular complexes undergoing self- or hetero-asso-
ciation have been applied to characterize Htt-exon1 oligo-
mers. Such methods include atomic force microscopy
(AFM), transmission electron microscopy (TEM), analyt-
ical ultracentrifugation, and confocal microscopy combined
with number and brightness analysis (12–14). Although
spherical oligomers of 5 nm have been reported, we recently
showed that the use of time-resolved small-angle neutron
scattering (TR-SANS), a powerful tool for uncovering the
nanoscale changes that an amyloid protein undergoes during
aggregation (15–17), can improve the structure resolution.
One striking feature of HD is that the longer the polyQ-
repeat, the earlier is the disease onset and the more severe
are the symptoms (18). Aggregation kinetics studies on
peptides containing only polyQ sequences showed that the
variations in aggregation rates were indeed Q-repeat lengthhttp://dx.doi.org/10.1016/j.bpj.2014.06.002
412 Perevozchikova et al.dependent (19,20). Since we had validated SANS as the
appropriate approach for acquiring real-time detailed struc-
tural information about the assembly pathway of the
metastable prefibrillar states leading to amyloid fibrils, we
questioned whether the observed variations in the kinetic ag-
gregation rates could in fact mirror important mechanistic
and structural differences in the fibrillization pathway, as
well as in the ultimate fibril structure. To track the mecha-
nistic differences and structural changes in early-formedolig-
omers and mature fibrils, we applied time-resolved SANS on
the nonpathologic peptide NtQ22P10 for direct comparison
with our previous study on the pathologic peptide NtQ42P10.MATERIALS AND METHODS
Materials
A peptide containing the sequence MATLEKLMKAFESLKSFQ22P10K2
(NtQ22P10) and molecular mass 6026 Da was synthesized by solid-phase
Fmoc chemistry (Keck-Yale facility) and purified by reverse-phase high-
performance liquid chromatography (HPLC). Trifluoroacetic acid
(TFA; >99.5%; Thermo Scientific), 1,1,1,3,3,3-hexafluoro-2-isopropanol
(HFIP; >99.5%; Acros Organics), 10 PBS powder (Fisher Scientific),
and D2O (99.9% D; Cambridge Isotope Laboratories, Andover, MA)
were used without further purification.Peptide preparation and HPLC assay
The NtQ22P10 peptide was handled as previously described (17). Briefly,
NtQ22P10 was dissolved in 50:50 TFA/HFIP, incubated for 3 h, and then
dried under argon gas. For HPLC kinetics, the peptide was solubilized
into 0.05% TFA D2O and ultracentrifuged for 2 h at 356,000  g, 4C.
The aggregation reaction was then initiated by bringing the supernatant
up to the desired concentration in 1 PBS D2O. The reaction was con-
ducted with a 130 mM starting monomer concentration at 20C. Aliquots
of the supernatant were injected into an analytical reverse-phase HPLC sys-
tem (model No. 1100 series HPLC; Agilent Technologies, Santa Rosa, CA)
and the peptide concentration was determined by using a standard curve
generated from NtQ22P10 and amino acid analysis.Thioflavin T fluorescence assay
We followed the formation of amyloid-like fibrils by measuring the increase
in Thioflavin T (ThT) fluorescence (21) using an LS 55 fluorescence spec-
trometer (Perkin-Elmer) with excitation and emission wavelengths set at
lex ¼ 450 nm and lem ¼ 482 nm, respectively. Measurements were made
by taking 20 ml of the ongoing aggregation reaction diluted with 130 ml
1 PBS D2O and then mixed with 5 ml of 2 mM ThT solution. Negative
controls also were run with an equivalent concentration of ThT and the
obtained signal was subtracted from the sample signal.TEM
TEM images were collected with the use of a Hitachi H-600 electron micro-
scope in the Biological Sciences Division, University of Tennessee.
Aliquots with mature fibrils of NtQ22P10 grown in 1 PBS D2O were fixed
to collodion/carbon grids and stained with a 1% uranyl acetate solution for
imaging. The diameter of a single fibril was measured at multiple different
positions on the obtained TEM image using the NIH software program
ImageJ (http://rsb.info.nih.gov/ij/) and converted from pixels to nanometers
using the image scale bar.Biophysical Journal 107(2) 411–421TR-SANS measurements
TR-SANS experiments were performed on the CG-3 Bio-SANS instrument
at the High Flux Isotope Reactor (Oak Ridge National Laboratory (ORNL),
Oak Ridge, TN). The neutron wavelength was set to 6 A˚with a wavelength
spread Dl/l ¼ 0.15. Scattered neutrons were detected with a 0.4  0.4 m
two-dimensional position-sensitive detector with 128  128 pixels that
was offset 175 mm relative to the direct beam. The sample-to-detector dis-
tance was 6.82 m to obtain the relevant wavevector transfer, q¼ 4p sin(q)/l,
where 2q is the scattering angle. Samples were loaded into 2 mm pathlength
circular-shaped quartz cuvettes (Hellma USA, Plainville, NY) and SANS
measurements were performed at 20C.
The sample preparation protocol used for NtQ42P10 (17) was also applied
to NtQ22P10. Once it became disaggregated, as described above, the argon-
dry NtQ22P10 was dissolved in 0.05% TFA D2O, brought up in 1 PBS
D2O, and centrifuged at 16,100  g for 2 min to remove any large particu-
lates. The supernatant was then taken for measurement. The final peptide
concentration was determined by reverse-phase HPLC to be 0.9 mg/ml
(150 mM). For time-resolved measurements, 15 min neutron exposure times
were initially collected. Longer exposure times, to improve the signal/noise
ratio, were achieved during data reduction by binning multiple, consecutive
15 min exposure runs. In the results for NtQ22P10, we binned 0–2 h and
0–8 h. All of the subsequent curves had 1 h exposure times, with the indi-
cated time corresponding to the end of the 1 h data collection window. Data
reduction was done according to standard procedures using IgorPro soft-
ware (WaveMetrics, Lake Oswego, OR) with SANS macros developed by
Dr. Ken Littrell (ORNL). The measured scattering intensity was corrected
for detector sensitivity and the scattering contribution from the solvent
and empty cuvette, and then placed on absolute scale using a calibrated stan-
dard (22). Data analysis details are described in the Results section below.Number of peptides and mass per length
calculations
The number of peptides comprising a species, npep, was calculated from the
SANS zero-angle scattering intensity, I(0) [cm1], by
npep ¼ Ið0ÞNA
MpepcðDrÞ2 y2
; (1)
where NA is Avogadro’s number, Mpep is the molecular mass of the peptide
(¼ 6026 g/mol for NtQ22P10 and 8586 g/mol for NtQ42P10), c (g/ml) is the
peptide concentration, Dr ¼ rprot  rD2O is the contrast in scattering length
density between the peptide and the D2O buffer solution, and y is the protein
partial specific volume (¼ 0.73 ml/g). The peptide scattering length density,
rprot (¼ 3.247  1010 cm2 for NtQ22P10 and 3.564  1010 cm2 for
NtQ42P10), was determined from the atomic composition using the program
CRYSON (23), which accounts for H/D exchange. The D2O scattering
length density used was rD2O ¼ 6.404  1010 cm2. Similarly, the mass
per length (ML) was evaluated from the intercept for two-dimensional anal-
ysis, Ic(0) [cm
1A˚1], by
ML ¼ Icð0ÞNA
pcðDrÞ2 y2; (2)
with the same values for rprot, rD2O, and y as above.RESULTS
SANS data analysis
We previously analyzed our NtQ42P10 TR-SANS data using
Guinier fitting and were able to discern two distinct regions
FIGURE 1 SANS on NtQ42P10 fibrils (89 mM peptide concentration) and
fit (solid line) using Eq. 5. The q3 power law contribution to the fit is also
shown (dashed line). Error bars: standard errors (SEs) from the radial
average of the intensity data on the neutron area detector.
Q Length Governs Htt-exon1 Structure 413(17). We classified these regions as two species present
within the length scale of our measurements and followed
their growth over time. Guinier analysis can be advanta-
geous for obtaining quantitative structural parameters for
an aggregating system because it is model independent
and relies on a minimal number of fit parameters. However,
when multiple species are present, the assumption that mul-
tiple Guinier regions are decoupled from each other can in
some cases be an oversimplification leading to inexact struc-
tural values. Singular value decomposition methods and
form factor fitting have been applied (24–26), but the shapes
of the individual species have to be known or assumed. This
motivated us to improve our SANS analysis approach to
make it applicable to any protein aggregation phenomenon
and thus ensure the accuracy of the structural results.
Similar to the treatment of multiple structural levels by
the unified model developed by Beaucage (27), we devel-
oped a sum of Guinier-Porod empirical models (28), with
each species present in the aggregating system accounted
for by a Guinier region and a Porod region. We find that
all of the data presented here are adequately described by
the combination of two Guinier-Porod models. An advan-
tage of this model is that it can account for shapes between
spheres and rods.
The conditional equation for the Guinier-Porod model,
IiðqÞ ¼ Gi
qsi
exp
"
q2R2g;i
3 si
#
for q%qi
IiðqÞ ¼ Di
qmi
for qRqi;
(3a)
describes the scattering intensity for a species i as a function
of scattering vector, Ii(q), where Rg,i is the radius of gyration,
3 – si is a dimensionality parameter (si ¼ 0, 1, and 2 for
spheres, rods, and plates, respectively),mi is the Porod expo-
nent, Gi is the Guinier scale factor, and Di is the Porod scale
factor. To impose continuity in this conditional equation,
qi ¼ 1
Rg;i
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
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q
ðmi  siÞ
i :
(3b)
Further details on this model and its parameters are
described in Hammouda (28). This allows the total scat-
tering intensity, Itotal(q), to be expressed as the sum of two
models for species 1 and 2:
ItotalðqÞ ¼ I1ðqÞ þ I2ðqÞ þ B; (4)
where B is the background constant. Our convention here is
that species 1 and 2 are the smaller and larger species,
respectively.For all of the SANS data presented here, the fitting pro-
cess involved a series of initial fits to ensure optimal final
fit convergence and robustness in the solution. The initial
fits included separately fitting the high-q and low-q portions
of the curve to obtain starting values for the species 1 and 2
parameters, respectively. The si and mi parameters routinely
converged to established integer values, within error. Three-
dimensional or two-dimensional scattering (si ¼ 0 or 1,
respectively) and rough or smooth surface scattering (mi ¼
3 or 4) were always observed. After their convergence
was verified, si and mi were then held fixed to refine the
fitting. Once the final fit result was obtained, all parameters
were set free to perform another fitting iteration, demon-
strating that no parameters had changed from the previously
determined fitting minimum.
To test our new (to our knowledge) SANS analysis
method, we applied Eq. 4 to our previously published scat-
tering data regarding the equilibrium state of NtQ42P10
fibrils (17) (Fig. 1) for comparison with the results presented
here. The iterative fitting process revealed a smaller species
with a rod-like shape (s1 ¼ 1) and a larger species. The
smaller species corresponds to the fibril cross section and
the larger species is due to bundling of fibrils. Since the
Guinier contribution of the larger species (species 2) is
beyond the length scale of our measurement, only the Porod
component has to be considered, reducing Eq. 4 to
ItotalðqÞ ¼ I1ðqÞ þ D2
qm2
þ B: (5)
This equation has a maximum of seven free parameters,
compared with the nine free parameters in Eq. 4. Further-
more, we could fix s1 ¼ 1, m1 ¼ 4, and m2 ¼ 3 in the refined
fitting and obtain a final fit that yielded Rg,1¼ 33.75 0.7 A˚,
G1 ¼ (2.51 5 0.07)  103 cm1 A˚1, D2 ¼ (1.72 5
0.08) 107 cm1 A˚3, and B¼ (2.55 0.1) 103 cm1.Biophysical Journal 107(2) 411–421
414 Perevozchikova et al.The power law scattering contribution from species 2
is shown in Fig. 1 to illustrate how it overlaps with the
higher q region where species 1 scattering is dominant.
This q3 dependence most likely results from the scattering
from rough surfaces related to the fibril bundles. For rod-
like forms, Rg,1 is the two-dimensional radius of gyration
of the cross section andG1 is the zero-angle scattering inten-
sity (¼ Ic,1(0)). The cylinder radius, R1 ¼
ﬃﬃﬃ
2
p
Rg;1 ¼ 48 5
1 A˚, and using Eq. 2, ML,1 ¼ 1470 5 40 Da/A˚. Although
the R1 value is comparable to our previously published
result, the ML,1 is slightly smaller because it accounts for
the underlying power law contribution of species 2 (R1 ¼
47 5 1 A˚ and ML,1 ¼ 1800 5 50 Da/A˚ (17)). However,
it is worth noting that this effect is minimal since the q3
scattering falls off quickly with increasing q.
We next turned to our TR-SANS data on Nt17Q42P10
aggregation (17). Preliminary fits to each scattering curve
indicated that Eq. 5 is most appropriate throughout the
time series (Fig. 2), similar to fitting the Nt17Q42P10 fibrils.
Species 2, corresponding to larger protein aggregates, is
always so large that only its Porod contribution is observed
within the q range of the measurements. An average B
(¼ 0.004 cm1) was found from the initial fits to all the
curves and held constant in each of the final fits. The first*
*
*
FIGURE 2 Time-resolved SANS profiles of NtQ42P10 (108 mM) showing
the collected time points (bottom to top): 0.43, 0.68, 0.93, 1.18, 1.43, 1.68,
1.93, 2.18, 2.43, 4.71, 4.98, 5.66, 6.53, and 18.04 h. The bottom curve is on
absolute intensity scale (cm1) and the subsequent curves are shifted up in
decade increments for clarity. All fits (solid lines) are with Eq. 5. Time
points showing three-dimensional scattering (s1 ¼ 0) are denoted (*). Error
bars: SEs from the radial average of the intensity data on the neutron area
detector.
Biophysical Journal 107(2) 411–421time point at 0.43 h demonstrates s1 ¼ 0 and m1 ¼ m2 ¼
4 in the refined fitting, which were held fixed in the final
fit to obtain Rg,1 and G1 with npep,1 calculated from G1
(¼ I1(0)) using Eq. 1 (see Table 1). Time points 0.68 and
0.93 h were similar except that m2 ¼ 3 and was held
constant. From time point 1.18 h and beyond, the scattering
of species 1 was predominantly for rod-like forms (s1 ¼ 1)
with m1 ¼ 4 and m2 ¼ 3, and these values again were held
constant in the final fits. Initial fits with s1 free illustrated a
sharp transition from three-dimensional to two-dimensional
scattering between 0.93 and 1.18 h. The complete fitting
results for Nt17Q42P10 are given in Table S1 in the Support-
ing Material.
Now considering the time-resolved measurements for
Nt17Q22P10 aggregation (Fig. 3), the initial fitting of all of
the curves with Eq. 4 gave the best values for si and mi
and an average value for B (¼ 0.003 cm1). Starting with
the 0–2, 0–8, and 12.7 h time points, two species that
were three-dimensional (s1 ¼ s2 ¼ 0) and had m1 ¼ m2 ¼
4 were found in these cases. With the background, dimen-
sion, and Porod exponent parameters fixed, Rg,i and Gi for
the two species were obtained, and then npep,1 was calcu-
lated from G1 (see Table 2). Species 2 corresponds to larger
protein aggregates. Fits to the SANS curves for 18.2 h and
beyond all showed a convergence to a single predominant
species with a rod-like shape (s1 ¼ 1) corresponding to
the single fibril cross section, so we reduced the fitting to
a single Guinier-Porod model with m1 ¼ 4 and I2(q) ¼ 0.
The complete fitting results for Nt17Q22P10 are given in
Table S2.NtQ22P10 aggregation kinetics and fibrils
We also assessed the NtQ22P10 kinetics by HPLC and ThT
fluorescence assays to monitor monomer loss (Fig. 4 A)
and fibril formation (Fig. 4 B), respectively. Single-expo-
nential fits to these curves show that the rates are nearly
coincident, with rate constants kmon ¼ 0.125 5 0.009 h1
and kfib ¼ 0.140 5 0.001 h1 for monomer loss and fibril
growth, respectively. Close inspection of the initial kinetics
(Fig. 4 B, inset) indicates an inflection in both the ThT
signal increase and the percentage of monomer converted
(¼ 100 – % monomer). This is suggestive of an initial lag
phase. The aggregation reaction reaches completion within
~40 h, where TEM illustrates that the resulting NtQ22P10
fibrils have a calculated fibril radius, R ¼ 50 5 6 A˚, with
a range of 39–64 A˚ (Fig. 4 C).TABLE 1 Structural parameters for NtQ42P10 early growth
Time (h)
Guinier-Porod 1 Power Law 2
Rg,1 (A˚) npep,1 m2 D2
0.43 12 5 7 1.35 0.3 4 (4.75 0.9)  1010
0.68 14 5 6 1.45 0.3 3 (6.85 0.9)  108
0.93 31 5 3 3.85 0.5 3 (1.25 0.1)  107
*
*
*
FIGURE 3 Time-resolved SANS profiles of NtQ22P10 (150 mM) showing
the collected time points (bottom to top): 0–2 h, 0–8 h, 12.7, 18.2, 19.2,
20.3, 21.3, 26.5, 36.4, 47, 52.3, and 55.5 h. The bottom curve is on absolute
intensity scale (cm1) and the subsequent curves are shifted up in decade
increments for clarity. Fits (solid lines) are with the multiple Guinier-Porod
model for 0–2 h, 0–8 h, and 12.7 h time points, and with the single Guinier-
Porod model for time points 18.2 h and beyond. Time points showing three-
dimensional scattering (s1 ¼ 0 and s2 ¼ 0) are denoted (*). Error bars: SEs
from the radial average of the intensity data on the neutron area detector.
A
B
C
FIGURE 4 (A) Aggregation kinetics of NtQ22P10 (130 mM, 1 PBS
D2O) monitored by the decrease in monomer concentration with an expo-
nential fit (solid line) and (B) increase in normalized ThT fluorescence
signal with an exponential fit (solid line). The initial kinetics (inset) for
ThT intensity (solid circles) and 100 – (% monomer) (open triangles) are
shown for clarity and comparison. (C) TEM image of the mature fibrils
formed by NtQ22P10 (150 mM, 1 PBS D2O).
Q Length Governs Htt-exon1 Structure 415No monomer/dimer formation occurs in the early
stages of NtQ22P10 growth
From the fits to the NtQ22P10 TR-SANS data (Fig. 3), the
early growth is found to exhibit an oligomeric species that
consists of six to eight peptides with Rg,1 ¼ 23 5 5 A˚
and remains stable over the first 8 h of the aggregation reac-
tion (Table 2). Not only is this oligomeric species, which we
refer to as a 7-mer for simplicity, the smallest species detect-
able, it also appears to be the initial one. A second species, a
larger protein aggregate with Rg,2¼ 1425 19 A˚, is likewise
detected over this initial 8 h period. The Rg,2 and Guinier
amplitude, G2, remain constant, within error, over this
time (see Table 2). We report G2 instead of M2 in Table 2
because more data at lower q would have been desirable
to ascertain whether a third species needed to be includedTABLE 2 Structural parameters for NtQ22P10 early growth
Time (h)
Guinier-Porod 1 Guinier-Porod 2
Rg,1 (A˚) npep,1 Rg,2 (A˚) G2
0–2 265 5 7 5 1 1495 28 0.115 0.04
0–8 235 5 7 5 1 1425 19 0.135 0.03
12.7 395 6 8 5 2 1345 14 0.215 0.03in the fits for a better characterization of species 2. However,
for reference, the 0–8 h G2 value would have equated to
npep,2 ¼ 27 5 7. By 12.7 h, an increase in the size of
NtQ22P10 species 1 is observed. We captured this last time
point before the multiple Guinier-Porod analysis transitions
to rod-like forms, indicative of the rapid elongation of the
forming fibrils beyond this time.
In the calculation of npep,1 using Eq. 1, we assumed a
pseudo-equilibrium for the initial phase of the aggregation
reaction with the total monomer concentration contributing
to the smallest species. Indeed, the smallest oligomeric spe-
cies observed by SANS are likely to remain in the superna-
tant during the ultracentrifugation step of the HPLC assayBiophysical Journal 107(2) 411–421
AB
C
FIGURE 5 Fibril growth monitored by time-resolved SANS. (A) Time-
dependent changes in NtQ22P10 Rc,1 (solid circles, left axis) and ML,1
(open triangles, right axis). An exponential fit with a time offset was
applied to the M data (solid line). (B) Time-dependent changes in
416 Perevozchikova et al.and therefore contribute to the measured monomeric peptide
concentration that is shown in Fig. 4 A. Additionally, a geo-
metric calculation from Rg,1 at 0–8 h, considering a spher-
ical shape, provides an upper bound of npep,1 % 15.
Further description is provided in the Discussion section.
The ~8 h lag time observed in the TR-SANS for NtQ22P10
is longer than the initial lag phase seen in the HPLC and
ThT fluorescence kinetic assays (see Fig. 4 B, inset). The
time discrepancy is likely to result from the population of
species detected by each method. As just described, detec-
tion of small oligomers by HPLC contributes to the differ-
ence from the SANS results. ThT fluorescence will be
sensitive to any formed species that intercalate the dye
molecule, including early oligomers such as the NtQ22P10
7-mer and any short fibrils. For TR-SANS, it is important
to remember that the curves cover a fixed length scale, prob-
ing structures below ~400 A˚ in the configurations used for
these particular measurements. SANS also is a weight-aver-
aged technique, where the three-dimensional size of the
oligomers will dominate over the thinner two-dimensional
cross section of any early-formed fibrils at the beginning
times of the TR-SANS measurements.
From our new (to our knowledge) analysis of the TR-
SANS after NtQ42P10 aggregation (Fig. 2), we found mono-
mer and dimer initially present with Rg,1 ¼ 12–14 A˚
(Table 1). Our prior fit to the 0.43 h time point provided
npep,1 ¼ 2.6 5 0.4 and Rg,1 ¼ 16.1 5 5.9 A˚ (17), so our
updated values are refined. To again validate the pseudo-
equilibrium condition, we calculated an upper range for
npep,1 from Rg,1 assuming a spherical shape, where npep,1
% 1.4 and 2.4 for the 0.43 and 0.68 h time points, respec-
tively. The multiple Guinier-Porod analysis revealed that
species 2, the larger protein aggregate species, is too large
to have its size quantified, but its growth can be followed
by the increase in the power law component, D2, with
time (Table 1).L,1
NtQ42P10 Rc,1 (solid circles, left axis) and ML,1 (open triangles, right
axis). Similarly to our prior analysis (17), ML,1 for time points 2.18, 2.43,
and 4.71 h were omitted due to sample sedimentation affecting the values.
An exponential fit with a time offset was applied to the ML,1 data (solid
line). (C) Plot of Rc,1 versusML,1 measured beyond 17 h for NtQ22P10 (solid
circles) and beyond 1 h for NtQ42P10 (open circles). Also shown are the
model calculations for a solid cylinder cross section (solid line) and the
Perutz hollow cylinder b-helix cross section (dashed line) for one, two,
and three filaments per fibril (open squares) as previously reported (17).
Errors bars: SEs from the corresponding model fits.Amyloid fibril structure is dictated by the Q-repeat
length
At 17 h into the aggregation reaction, the NtQ22P10 7-mer
intermediate progressively grows in mass and shape anisot-
ropy toward a pronounced fibrillar structure. Similarly, by
1 h the initial pool of NtQ42P10 monomer/dimer rapidly
grows toward fibrils. Since the length of the growing fibrils
exceeds the upper length scale of SANS, only the two-
dimensional fibril cross section is monitored with si going
from 0 to 1 in the fits. The SANS fits yield the time depen-
dence for the Rc,1 and ML,1 of the growing NtQ22P10
(Fig. 5 A) and NtQ42P10 (Fig. 5 B) fibrils. To accurately
calculate ML in both cases, we accounted for the concentra-
tion of peptide converted into fibrils using the rate constants
obtained for monomer loss (with kmon ¼ 1.28 5 0.09 h1
for NtQ42P10 (17),). Replacing c by [c(0) – c(t)] in Eq. 2
gives ML,1(t) as shown in Fig. 5, A and B, for NtQ22P10Biophysical Journal 107(2) 411–421and NtQ42P10, respectively. Similar to our prior NtQ42P10
analysis (17), ML for time points 2.18, 2.43, and 4.71 h
were omitted due to sample sedimentation, but all Rc values
are shown because they appear unaffected.
For NtQ22P10, no additional changes in the sample scat-
tering intensity could be detected beyond 36 h, signifying
that structural changes across the length scale of our
SANS measurements reached completion. In Fig. 5 A, the
Rc reaches a plateau of ~38.6 5 0.4 A˚, as indicated from
FIGURE 6 Normalized two-dimensional pair-distance distribution func-
tions, Pc(r), obtained for the mature fibrils of NtQ22P10 (gray line) and
NtQ42P10 (black line).
Q Length Governs Htt-exon1 Structure 417the Guinier-Porod fit to the 55.5 h time point. With
R1 ¼
ﬃﬃﬃ
2
p
Rg;1 ¼ 54.65 0.6 A˚, the radius of the final fibrils
matches the average fibril radius determined by TEM (R ¼
50 5 6 A˚; Fig. 4 C).
Fibril formation in both systems followed exponential
growth. Fitting the NtQ22P10 ML to a single exponential
with a time offset, t0 (Fig. 5 A), yielded ML,1(N) ¼
7330 5 40 Da/A˚ and kfib,1 ¼ 0.150 5 0.004 h1 with
t0¼ 18.2 h. For NtQ42P10ML,1 in Fig. 5 B, the same fit equa-
tion gave ML,1(N) ¼ 1820 5 30 Da/A˚ and kfib,1 ¼ 2.7 5
0.5 h1 with t0 ¼ 1.18 h. As expected, NtQ42P10 fibrilliza-
tion occurred earlier and proceeded faster than NtQ22P10
fibrillization. Interestingly, the mass densities of wild-type
and pathological fibrils were distinctly different, with
NtQ22P10 fibrils having a higher ML compared with
NtQ42P10. The cross-sectional size of the end-state fibrils
was also larger in NtQ22P10 larger than in NtQ42P10, but
not proportional to the magnitude difference inML. To care-
fully investigate these structural differences, we removed
the time component by plotting Rc,1 versus ML,1 (Fig. 5 C)
measured beyond 17 h for NtQ22P10 and beyond 1 h for
NtQ42P10. Also shown in Fig. 5 C are the model calculations
for a solid cylinder cross section and the Perutz hollow cyl-
inder b-helix cross section for one, two, and three filaments
per fibril as previously reported (17). From the cross section
and mass density values, we assessed the internal fibril
packing of NtQ22P10, which follows a solid cylinder model
and not the Perutz model. The solid cylinder model has
peptide homogeneously filling the cross section, which
more resembles the sterical zipper model. The NtQ22P10
early fibrillization time points from 17 to 21 h are seen to
converge onto the solid cylinder model calculation with
time, which may result from peptide folding and packing
optimization in these intermediate states that ultimately
lead toward mature fibrils. From 25 h to the end of the reac-
tion, the NtQ22P10 data closely agree with the solid cylinder
model. NtQ42P10 fibril packing closely follows the Perutz
model (29), with formation of hollow cylinder filaments
that compose the fibril as we previously reported for the
pathological Q-repeat length.
To obtain the cross-sectional shapes of the NtQ22P10 and
NtQ42P10 mature fibrils, we calculated the cross-sectional
pair distance distribution function, Pc(r), as an indirect
Fourier transform from the fibril SANS curves using
GNOM (30) (Fig. 6). For NtQ22P10, the scattering curve
for the last time point at 55 h was used. For NtQ42P10, we
used the SANS profile for the fibril sample that was pre-
pared at 89 mM in 1 PBS D2O buffer and allowed to aggre-
gate for >500 h at 22C, where we first subtracted the q3
contribution shown in Fig. 1 before determining Pc(r).
The Pc(r) profiles were normalized to their respective
peak maxima for comparison. Fits to the NtQ22P10 and
NtQ42P10 fibril SANS data to obtain Pc(r) are shown in
Fig. S1 A and B, respectively. The Pc(r) profiles illustrate
how the fibril cross-sectional shapes of NtQ22P10 andNtQ42P10 are pronouncedly different, in addition to the
above-mentioned disparities in their peptide internal pack-
ing. Overall, the NtQ22P10 fibril cross section is more asym-
metric because it extends to larger radial distances
compared with the NtQ42P10 fibrils. Both Pc(r) profiles
show a tail at larger radial distances, but NtQ22P10 is more
prominent as indicated by its maximum linear dimension,
rmax (~125 A˚), being 3.3 the peak maximum
(¼ 37.5 A˚). The NtQ42P10 peak maximum (¼ 38 A˚) is
nearly identical to that of NtQ22P10, but with an rmax
(~95 A˚) that is just 2.5 greater than this value. In addition,
the NtQ42P10 Pc(r) profile displays a shoulder at smaller dis-
tances near 16 A˚, where no shoulder is observed in the
NtQ22P10 Pc(r) profile. The calculated Pc(r) profiles yield
Rc ¼ 38.4 5 0.4 A˚ and Ic(0) ¼ (1.88 5 0.01)  102
cm1 A˚1 for NtQ22P10 and Rc ¼ 32.0 5 0.8 A˚ and
Ic(0) ¼ (2.44 5 0.06)  103 cm1 A˚1 for NtQ42P10.
The calculated ML values are 7310 5 40 and 1420 5 30
Da/A˚ for NtQ22P10 and NtQ42P10, respectively. Both the
Rc and ML values are in good agreement with those deter-
mined from our multiple Guinier-Porod analysis. As before,
we calculated the actual and maximum number of peptides
per 4.75 A˚ b-sheet repeat, nL ¼ (4.75 A˚) ML/Mpep and
nL;max ¼ 2ð4:75 AÞpR2cNA=yMpep, from ML and Rc, respec-
tively. Using the Pc(r) results, NtQ22P10 fibrils have nL ¼
5.76 5 0.03 with nL,max ¼ 6.02 5 0.09, and NtQ42P10 fi-
brils have nL ¼ 0.79 5 0.02 with nL,max ¼ 2.9 5 0.1. For
NtQ22P10, nL z nL,max, which reiterates how the internal
structure of these fibrils is one that nearly optimally fills
the cross section. For NtQ42P10, nL < nL,max, as we have
noted before, and is consistent with the Perutz b-helix
model.Refined visualizations of the fibril cross sections
From our SANS results, as well as other prevailing struc-
tural details of amyloid fibrils and Htt-exon1 fragments,Biophysical Journal 107(2) 411–421
418 Perevozchikova et al.we created refined visualizations of the fibril cross sections.
Beginning with NtQ22P10 fibrils, the constraints of the Rc
andML support a slab-like structure, where we can consider
that for many laminated b-sheet amyloids the x-ray fiber
diffraction pattern shows a 10 A˚ equatorial reflection indic-
ative of the structural spacing of neighboring b-sheets. Also,
a b-strand in an antiparallel configuration translates 3.2 A˚/
residue so that a well-ordered Q22 core with six peptides
per cross section would yield dimensions of ~60  70.4 A˚
with a 32.6 A˚ average half-width (Fig. 7 A). The peak
maximum in the NtQ22P10 Pc(r) profile suggests the pres-
ence of a well-ordered core region with ~38 A˚ half-width
that is near this calculated average half-width. Pc(r) correla-
tions beyond the maximum linear dimension of the Q22 core
then would correspond to the N- and C-terminal flanking
regions that reside on the exterior of the NtQ22P10 fibril.
We can calculate the total fibril cross-sectional rmax by ac-
counting for the 17 N-terminal amino acids in an a-helical
conformation, as previously reported (4,5,31,32), with a
1.5 A˚ rise per residue yielding a 25.5 A˚ length. We estimate
the a-helical Nt to be slightly longer than the P10 region for
both random coil and type II polyproline helix conforma-
tions of P10. Therefore, the contribution given by Nt is
considered dominant for the purposes of these length calcu-
lations. The diagonal of the total cross section gives rmax of
135.4 A˚, and the experimental rmax of 125 A˚ is close to
this value. Lastly, the NtQ22P10 rectangular cross section
matches the asymmetry seen in its Pc(r) profile.FIGURE 7 (A) Visualization of the NtQ22P10 fibril cross section based on
the constraints provided by the SANS data. The NtQ22P10 fibril has approx-
imately six peptides per 4.75 A˚ b-sheet repeat, with theQ22 region (b-strands
represented by arrows) forming the core and the 17 N-terminal (represented
as a-helices) and P10 (represented as type II polyproline helices) regions on
the exterior. The dimensions of the Q22 core and length of the 17 N-terminal
a-helix are given. (B) Visualization of the NtQ42P10 fibril cross section,
where NtQ42P10 has ~1–1.5 peptides per 4.75 A˚ b-sheet repeat. The Q42
region forms a b-helix (represented by the arrow) within a single filament,
and the 17 N-terminal (represented as a-helices) and P10 (represented as
type II polyproline helices) regions reside on the periphery of the filaments.
The fibril is composed of two to three filaments, with three filaments dis-
played in the schematic. The dimensions of the b-helical filament outer
diameter and length of the 17 N-terminal a-helix are given.
Biophysical Journal 107(2) 411–421For NtQ42P10, both our previous findings and new (to our
knowledge) SANS analysis based on Rc and ML values
demonstrate that the fibril structure agrees with the Perutz
b-helix model having approximately one peptide per cross
section (29). Our value for nL suggests two to three filaments
per fibril based on this model (Fig. 7 B). Incorporating
knowledge about the cross-sectional shape from the
NtQ42P10 Pc(r) profile (Fig. 6), the peak maximum of
37.5 A˚ in the Pc(r) closely coincides with the outer diameter
of a single filament (¼ 31.8 A˚), where two to three filaments
per fibril would make the average half-width of the Q42 core
approximately equal to the single filament diameter. The
shoulder around 16 A˚ in the Pc(r) then may be due to corre-
lations about the hollow cylinder shape of a filament, which
has an internal diameter of 11.8 A˚. Radial distances
approaching rmax in the Pc(r) would reflect atomic correla-
tions of the Nt and P10 portions of the peptide, as they pref-
erentially reside on the exterior. With the 25.5 A˚ length
contribution by the a-helical Nt at the periphery of each fila-
ment, a calculated rmax ~100 A˚ is obtained based on an equi-
lateral triangle shape to the cross section having three
filaments. The experimental rmax of 95 A˚ closely matches
this value. Furthermore, the nearly symmetric arrangement
in the Fig. 7 B schematic is consistent with the near symme-
try of the overall Pc(r) profile for NtQ42P10.DISCUSSION
Although the accumulation of insoluble b-sheet-rich protein
assemblies in disease-targeted neurons is the principal hall-
mark of many neurodegenerative amyloid disorders, no
clear consensus has been reached so far regarding the struc-
tural identity of the pathologic species. Because the on-
pathway oligomeric intermediates are currently thought to
be the primary suspects for causing HD neuronal cell death,
the importance of elucidating the aggregation pathway of
Htt-exon1, with a special emphasis on the oligomerization
steps, is clear. Thus, it is critical to obtain thorough struc-
tural and mechanical knowledge about the process before,
during, and after amyloid fibrillization. Aside from results
of computational studies (33–37), little experimental data
regarding the structural changes of Htt-exon1 before nucle-
ation can be found in the literature (5,38). As for the oligo-
meric stages of Htt-exon1, spherical oligomers of ~5 nm
diameter have been reported (12,39–41). Only recently did
we demonstrate that by using TR-SANS, we could follow
the time course of Htt-exon1 peptide fibrillization in solu-
tion with sufficient resolution to discriminate among the
different oligomer sizes, as we observed for NtQ42P10
(17). Here, we took advantage of this technique to investi-
gate the effect of the Q-repeat length on the Htt-exon1 olig-
omers and fibril on-assembly pathway. We also improved
upon our SANS data fitting by adapting a summation of
Guinier-Porod empirical models (28) that can satisfactorily
account for multiple species present in solution. This
Q Length Governs Htt-exon1 Structure 419provides a general and robust analysis approach for small-
angle scattering data to monitor protein aggregation from
early growth to mature fibrils.
We were able to identify the intermediate conformations
that might be responsible for Htt-exon1 toxicity by
comparing the aggregation properties of NtQ42P10 and a
nonpathogenic Htt-exon1, NtQ22P10. Clearly, the role
played by the polyQ-repeat length is quite substantial, as
NtQ22P10 and NtQ42P10 assemble and pack differently.
Diminishing the pathologic fragment by 20 glutamines
leads to dramatic alterations in the assembly pathway. The
first events in the oligomerization process of NtQ22P10 do
not include the formation of a dimer, as is the case for the
pathological length, but instead comprise a transition step
of monomer into a long-lived 7-mer (npep,1 ¼ 7 5 1) with
Rg,1¼ 235 5 A˚. Even with slower kinetics to better resolve
the earliest structural changes, the initial steps of NtQ22P10
fibrillization do not appear to occur through simple mono-
mer addition as does NtQ42P10 early growth. The key fea-
tures displayed by the pathological length are starting
monomer-to-dimer structures that are compact with Rg,1 ¼
12–14 A˚. Monomer adoption of a b-helical conformation,
with templating to form dimers and higher oligomers, is
consistent with these features.
Based on our peptide concentration correction applied to
obtain accurate ML values, we considered the implications
of an analogous correction for the early stage npep calcula-
tions. We again used the kinetic rate constant for monomer
loss to correct the peptide concentration by assuming that
all remaining monomer contributes to oligomers, with c ¼
c(t) in Eq. 1. This would slightly shift npep,1 values in Tables
1 and 2. However, spherical shape calculations based onRg to
obtain upper bounds on npep indicate that the pseudo-equilib-
riumvalues reported in Tables 1 and 2 aremost reasonable for
the first two time points of both NtQ22P10 and NtQ42P10. It
does appear that a c(t) correction is needed for the 12.7 h
NtQ22P10 and 0.93 h NtQ42P10 time points, where the Rg
calculation indicates npep % 73 and 26, respectively.
Applying the c(t) correction would update npep,1 ¼ 405 9
for 12.7 h NtQ22P10 and npep,1¼ 145 2 for 0.93 h NtQ42P10.
It is possible that the 7-mer might be the critical nucleus
required for further aggregation of NtQ22P10. Structural
characterization of the fibrillization nucleus can be difficult
because it is the thermodynamically least-favorable species
at low concentrations. Powers and Powers (42) have shown
that it becomes thermodynamically stable and accumulates
above a supercritical concentration. The nucleus is therefore
no longer a thermodynamic nucleus, but a structural
nucleus. In this way, the peptide concentrations necessary
for our SANS measurements may actually assist in driving
the stabilization of the nucleus. Additionally, Kar et al.
(43) recently found that the size of the critical nucleus for
polyQ alone peptides is also Q-repeat length dependent,
increasing with decreasing Q-repeat length. Our TR-SANS
results regarding the early stages of fibrillization parallelthis effect, with a 7-mer for NtQ22P10 that reduces down
to monomer/dimer for NtQ42P10. A resulting mechanistic
implication, which is in contrast to what has been reported
for Htt-exon1 fragments with longer Q-repeats (R30)
(41), is that NtQ22P10 does not appear to assemble via a
two-step mechanism with nonnucleated downhill formation
of nonamyloid oligomeric intermediates. However, addi-
tional experiments are needed to confirm that the formed
NtQ22P10 7-mer is the true critical nucleus.
The decrease in Q-length for Htt-exon1 fragments also is
responsible for converting the final fibril internal structure
into one with a significantly higher peptide packing density.
From our model comparisons with the resulting fibrils, this
reduction from 42 to 22 Q resembles a transition from
hollow b-helical filaments into the more commonly seen
amyloid structure type, laminated b-sheets (44,45).
Although slab-like aggregates with the zipper model is a
configuration that is fully accepted by the amyloid commu-
nity, that is not the case for water-filled polyQ nanotubes.
Our experiments suggest that the laminated b-sheet arrange-
ment found for NtQ22P10 fibrils does not appear reasonable
for NtQ42P10 based on the ML and Rc restrictions. In addi-
tion, a very recent computational study reported the sponta-
neous formation of a double-stranded, antiparallel b-sheet
polyQ40 nanotube that serves as a building block to form
longer nanotubes with higher structural stability, which is
reinforced by the presence of the 17 N-terminal residues
(37). Finally, a compact antiparallel b-sheet conformation
(33) appears to be a prerequisite to induce oligomerization
and cell toxicity when enforced in the polyQ sequence of
the Htt-exon1 by the N-terminus (37). An instructive next
step would be to perform fiber diffraction (45) as a com-
plement to our SANS structural studies, and to more con-
clusively characterize the internal fibril structure of the
NtQ42P10 fibrils. Also, because many amyloid-like peptides
can exhibit polymorphisms in their fibril structure (46), it is
important to keep in mind that solution conditions can cause
different end-state morphologies to emerge.CONCLUSIONS
Our TR-SANS results provide new (to our knowledge) and
important insights into the protein aggregation phenomena
that occur in HD. We found that the length of the glutamine
repeat plays a major role in directing the structures under-
taken by the polymerizing Htt-exon1-like peptides along
the aggregation pathway. Incorporating the structural dis-
parities we describe here between wild-type and pathologic
Htt-exon1, and between early oligomers and the final fibrils,
should help establish the true structural basis of this disease.SUPPORTING MATERIAL
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